Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY

v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings
Noncontrolling Interests
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022   19,093,000      
Beginning balance at Dec. 31, 2022 $ 147,047 $ 121,583 $ 34,635 $ 4,142 $ (13,313)
Increase (Decrease) in Shareholders' Equity          
Share-based compensation expense 4,893 $ 4,893      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)   206,000      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (385) $ (385)      
Repurchase of common stock (in shares)   (424,000)      
Repurchase of common stock (6,397) $ (6,397)      
Net income 16,416   15,076 1,340  
Other comprehensive loss $ (2,034)       (2,034)
Ending balance (in shares) at Dec. 31, 2023 18,875,000 18,875,000      
Ending balance at Dec. 31, 2023 $ 159,540 $ 119,694 49,711 5,482 (15,347)
Increase (Decrease) in Shareholders' Equity          
Share-based compensation expense 4,788 $ 4,788      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)   148,000      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax $ (1,046) $ (1,046)      
Repurchase of common stock (in shares) (540,000) (540,000)      
Repurchase of common stock $ (8,859) $ (8,859)      
Net income 7,892   7,696 196  
Other comprehensive loss $ (1,324)       (1,324)
Ending balance (in shares) at Dec. 31, 2024 18,483,000 18,483,000      
Ending balance at Dec. 31, 2024 $ 160,991 $ 114,577 $ 57,407 $ 5,678 $ (16,671)